Patents by Inventor Jaime E. VILLEGAS OLAVARRIA

Jaime E. VILLEGAS OLAVARRIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS
    Publication number: 20230040280
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Application
    Filed: March 25, 2022
    Publication date: February 9, 2023
    Inventors: Luis O. Burzio Eriz, Veronica A. Burzio Menendez, Jaime E. Villegas Olavarria
  • Antisense oligonucleotides for treatment of cancer stem cells
    Patent number: 11319535
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: May 3, 2022
    Assignee: ANDES BIOTECHNOLOGIES GLOBAL, INC.
    Inventors: Luis O. Burzio Eriz, Veronica A. Burzio Menendez, Jaime E. Villegas Olavarria
  • ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS
    Publication number: 20200239885
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Application
    Filed: September 17, 2019
    Publication date: July 30, 2020
    Inventors: LUIS O. BURZIO ERIZ, VERONICA A. BURZIO MENENDEZ, JAIME E. VILLEGAS OLAVARRIA
  • Antisense oligonucleotides for treatment of cancer stem cells
    Patent number: 10457943
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: October 29, 2019
    Assignee: Andes Biotechnologies Global Inc.
    Inventors: Luis O. Burzio Eriz, Veronica A. Burzio Menendez, Jaime E. Villegas Olavarria
  • Methods for detecting and treating multiple myeloma
    Patent number: 10066269
    Abstract: The invention provides methods for using the expression levels and subcellular localization of non-coding mitochondrial RNAs to select individuals or subpopulation of individuals for treatment with an anticancer therapy for multiple myeloma. Additional methods provided herein are useful for determining whether an individual in remission for multiple myeloma following successful treatment will be likely to suffer a relapse as well as to identify individuals who have suffered a relapse of multiple myeloma.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 4, 2018
    Assignee: ANDES BIOTECHNOLOGIES GLOBAL, INC.
    Inventors: Claudio E. Villota Arcos, Jaime E. Villegas Olavarria, Veronica A. Burzio Menendez, Luis O. Burzio Eriz
  • ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS
    Publication number: 20180171335
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Application
    Filed: November 29, 2017
    Publication date: June 21, 2018
    Inventors: Luis O. Burzio Eriz, Veronica A. Burzio Menendez, Jaime E. Villegas Olavarria
  • Antisense oligonucleotides for treatment of cancer stem cells
    Patent number: 9862944
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: January 9, 2018
    Assignee: ANDES BIOTECHNOLOGIES S.A.
    Inventors: Luis O. Burzio Eriz, Veronica A. Burzio Menendez, Jaime E. Villegas Olavarria
  • METHODS FOR DETECTING AND TREATING MULTIPLE MYELOMA
    Publication number: 20160138109
    Abstract: The invention provides methods for using the expression levels and subcellular localization of non-coding mitochondrial RNAs to select individuals or subpopulation of individuals for treatment with an anticancer therapy for multiple myeloma. Additional methods provided herein are useful for determining whether an individual in remission for multiple myeloma following successful treatment will be likely to suffer a relapse as well as to identify individuals who have suffered a relapse of multiple myeloma.
    Type: Application
    Filed: March 14, 2014
    Publication date: May 19, 2016
    Inventors: Claudio E. VILLOTA ARCOS, Jaime E. VILLEGAS OLAVARRIA, Veronica A. BURZIO MENENDEZ, Luis O. BURZIO ERIZ
  • ANTISENSE OLIGONUCLTEOTIDES FOR TREATMENT OF CANCER STEM CELLS
    Publication number: 20160138015
    Abstract: The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).
    Type: Application
    Filed: March 14, 2014
    Publication date: May 19, 2016
    Applicant: Andes Biotechnologies S.A.
    Inventors: Luis O. BURZIO ERIZ, Veronica A. BURZIO MENENDEZ, Jaime E. VILLEGAS OLAVARRIA